|
Market Closed -
Warsaw S.E.
16:55:50 02/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 130.00 PLN | -1.07% |
|
-7.28% | -4.55% |
| 05-27 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| 05-15 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 223.9 | +70.4% | 1 | ||||
| 25.07 | +3.01% | 7 | ||||||
| 10 | +20.77% | 9 | ||||||
| 57.82 | +33.13% | 11 | ||||||
| 52.33 | +6.87% | 6 | ||||||
| - | - | 51.14 | +32.11% | 1 | ||||
| - | 45,500 | +37.88% | 2 | |||||
| 7.3 | - | 5 | ||||||
| 8.25 | +114.84% | 4 | ||||||
| Average | 5,103.98 | +39.88% | 5 | ||||||
| Weighted average by Cap. | 2,759.67 | +20.78% | 7 |
- Stock Market
- Stocks
- SCP Stock
- Sector Scope Fluidics S.A.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
